| Predicate |
Object |
| contentType |
Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review |
| endingPage |
10 |
| issn |
1179-2019
1174-5878 |
| issueIdentifier |
1 |
| pageRange |
1-10 |
| publicationName |
Paediatric drugs |
| startingPage |
1 |
| bibliographicCitation |
MacDonald KD, McKenzie KR, Zeitlin PL. Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation. Paediatr Drugs. 2007;9(1):1–10. doi: 10.2165/00148581-200709010-00001. PMID: 17291132. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0df7a596193d8936a9878e558fd7d697
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb556da210813103c6f66c944194725a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fea55b32ed490039970acb6fec563d93 |
| date |
200701 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/17291132
https://doi.org/10.2165/00148581-200709010-00001 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1174-5878
https://portal.issn.org/resource/ISSN/1179-2019
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21798 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation |
| discusses |
http://id.nlm.nih.gov/mesh/M0475665
http://id.nlm.nih.gov/mesh/M0028383 |